Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection

BACKGROUND/AIMS: It is important to identify patients who are refractory to transarterial chemoembolization (TACE), which is performed for the treatment of hepatocellular carcinoma (HCC). We investigated the predictors of poor treatment outcomes in patients with recurrent HCC treated who were treate...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, Mi Young, Kim, Hye Soo, Lim, Tae Seop, Han, Dai Hoon, Kim, Beom Kyung, Park, Jun Yong, Kim, Do Young, Ahn, Sang Hoon, Choi, Gi Hong, Choi, Jin Sub, Han, Kwang-Hyub, Kim, Seung Up
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449032/
https://www.ncbi.nlm.nih.gov/pubmed/30947275
http://dx.doi.org/10.1371/journal.pone.0214613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449032/
https://www.ncbi.nlm.nih.gov/pubmed/30947275
http://dx.doi.org/10.1371/journal.pone.0214613

Ejemplares similares